Document is current
Any future updates will be listed below
-
Authors
Wang, Yujing
Chen, Jiahui https://orcid.org/0009-0004-3969-4748
Tang, Qinglian
Qin, Xu
Wang, Shuxian
Xi, Chuchu
Lu, Zhaowen
Ren, Kerui
Xue, Chu
Shen, Jianhua
Wang, Kai https://orcid.org/0000-0002-7597-549X
Zhu, Michael X https://orcid.org/0000-0002-5676-841X
Yu, Jie https://orcid.org/0009-0005-9379-6988
Cao, Zhengyu https://orcid.org/0000-0002-2692-2949
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (82100585)
the National Natural Science Foundation of China (82373929)
Shanghai Basic Research Pioneer Project
Major Program for New Drug Development (LGL-2612-09)
Jiangsu Province Major Science and Technology Projects (BG2024046)
Double First Class University Project (CPU2025CXY02)
- License Information
-
More Information
Article History
Received: 25 November 2025
Revised: 10 July 2026
Accepted: 21 July 2026
First Online: 13 August 2026
Disclosure and competing interests statement
: Author Zhengyu Cao is the founder of Nanjing Poregen Biotechnology Co., Ltd. The company had no role in the study design, data collection, data analysis, manuscript preparation, or the decision to publish. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
